ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $884,000 | +0.8% | 605,241 | -2.0% | 0.00% | – |
| Q4 2016 | $877,000 | +24.2% | 617,881 | +53.1% | 0.00% | – |
| Q3 2016 | $706,000 | -13.8% | 403,467 | -15.8% | 0.00% | – |
| Q2 2016 | $819,000 | +31.5% | 478,925 | +51.3% | 0.00% | – |
| Q1 2016 | $623,000 | -75.7% | 316,443 | -76.5% | 0.00% | -100.0% |
| Q4 2015 | $2,561,000 | -12.7% | 1,347,802 | -12.3% | 0.00% | 0.0% |
| Q3 2015 | $2,934,000 | -60.0% | 1,536,241 | -2.9% | 0.00% | -50.0% |
| Q2 2015 | $7,339,000 | +18.6% | 1,581,849 | +11.7% | 0.00% | 0.0% |
| Q1 2015 | $6,188,000 | +11.1% | 1,415,759 | -11.8% | 0.00% | +100.0% |
| Q4 2014 | $5,571,000 | -22.8% | 1,605,664 | -6.7% | 0.00% | -50.0% |
| Q3 2014 | $7,214,000 | -8.1% | 1,721,798 | +28.5% | 0.00% | 0.0% |
| Q2 2014 | $7,852,000 | -30.5% | 1,339,864 | -25.3% | 0.00% | -50.0% |
| Q1 2014 | $11,300,000 | +149.7% | 1,793,662 | +131.9% | 0.00% | +300.0% |
| Q4 2013 | $4,525,000 | -5.2% | 773,604 | -14.6% | 0.00% | 0.0% |
| Q3 2013 | $4,773,000 | -58.9% | 905,716 | -39.9% | 0.00% | -75.0% |
| Q2 2013 | $11,605,000 | -7.2% | 1,507,095 | +8.7% | 0.00% | -20.0% |
| Q4 2012 | $12,506,000 | +19.0% | 1,386,575 | +9.8% | 0.01% | +25.0% |
| Q3 2012 | $10,510,000 | -24.0% | 1,263,195 | -8.9% | 0.00% | -42.9% |
| Q2 2012 | $13,831,000 | +2369.8% | 1,386,517 | +661.7% | 0.01% | – |
| Q1 2012 | $560,000 | – | 182,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |